Skip to Main Content
Insider Trading

Terrence A Duffy Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 2 days ago

Terrence A Duffy has an estimated net worth of at least $36.8 million*, as of Dec. 11, 2024. They own 94,911 shares of CME stock. They have sold 70,000 shares of CME stock since 2021, for an estimated $14.1 million.

Terrence A Duffy $CME SEC Form 4 Insider Trading

Terrence A Duffy has filed a total of 11 insider trades in $CME since 2021. Their most recent trade was a sale of 4,076 shares, made on Apr 29, 2024. Their largest trade was a sale of 30,000 shares, made on Aug 18, 2023. We estimate that they now own 94,911 shares of $CME, worth an estimated $22.6 million.



Insider Trading at $CME

There have been a total of 116 insider trades reported at $CME since 2021, with 57,436 shares purchased and 253,948 shares sold. The most active insider traders in $CME stock have been Terrence A Duffy, Hilda Harris Piell, and Timothy Francis Mccourt. The most recent trade was a sale of 750 shares reported by Elizabeth A Cook (None), made on Nov 12, 2024.



History of Insider Stock Trades by Terrence A Duffy

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
CME Sale 4,076 Apr 29, 2024 May 1, 2024, 5:06 p.m.
CME Sale 10,708 Apr 29, 2024 May 1, 2024, 5:06 p.m.
CME Sale 25,216 Apr 29, 2024 May 1, 2024, 5:06 p.m.
CME Sale 30,000 Aug 18, 2023 Aug. 21, 2023, 4:20 p.m.
CME Purchase 400 Nov 05, 2021 Nov. 7, 2021, 8 p.m.
CME Purchase 200 Nov 04, 2021 Nov. 4, 2021, 8 p.m.
CME Purchase 300 Nov 04, 2021 Nov. 4, 2021, 8 p.m.
CME Purchase 600 Nov 04, 2021 Nov. 4, 2021, 8 p.m.
CME Purchase 100 Nov 04, 2021 Nov. 4, 2021, 8 p.m.
CME Purchase 100 Nov 04, 2021 Nov. 4, 2021, 8 p.m.
CME Purchase 300 Nov 04, 2021 Nov. 4, 2021, 8 p.m.




$CME Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.